Eastern Bank’s Prime Medicine PRME Stock Holding History

Eastern Bank’s Portfolio PRME Stock Details PRME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-134	Closed	-$494	–	1132
2026 Q2	$494	Buy	+134	New	+$445	﹤0.01%	1011

Other funds holding PRME

GAA

Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return

MAM

Milestone Asset Management Pittsburgh, Pennsylvania $631M AUM 19.64% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

Eastern Bank's PRME Position: Q3 2026 in Review

Eastern Bank sold out of Prime Medicine (PRME) in Q3 2026, closing a stake of 134 shares — an estimated $494 sold.

Eastern Bank first reported a position in PRME in Q2 2026 and held it in 1 quarter. The position peaked at $494 in Q2 2026. 6 funds tracked by Wall St. Rank hold PRME as of Q3 2026.

Eastern Bank reported no remaining Prime Medicine position as of Q3 2026 after selling out during the quarter.
Eastern Bank sold 134 Prime Medicine shares in Q3 2026, an estimated $494.
Eastern Bank first reported a position in Prime Medicine in Q2 2026 and held it in 1 quarter.
Eastern Bank's Prime Medicine position peaked at $494 in Q2 2026.
6 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.